| PERIOD ENDING | 31-Dec-09 | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | | Total Revenue | 21,027,000 | 19,807,000 | 18,662,000 | 18,417,000 | | Cost of Revenue | 9,736,000 | 9,398,000 | 9,267,000 | 9,161,000 | | | Gross Profit | 11,291,000 | 10,409,000 | 9,395,000 | 9,256,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 6,636,000 | 5,961,000 | 5,822,000 | 5,526,000 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 4,655,000 | 4,448,000 | 3,573,000 | 3,730,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 53,000 | 23,000 | 40,000 | 93,000 | | Earnings Before Interest And Taxes | 4,708,000 | 4,471,000 | 3,613,000 | 3,823,000 | | Interest Expense | 224,000 | 287,000 | 329,000 | 336,000 | | Income Before Tax | 4,484,000 | 4,184,000 | 3,284,000 | 3,487,000 | | Income Tax Expense | 1,335,000 | 1,157,000 | 813,000 | 902,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 3,149,000 | 3,027,000 | 2,471,000 | 2,585,000 | | | Non-recurring Events | | Discontinued Operations | 1,510,000 | 280,000 |
-
| 28,000 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 4,659,000 | 3,307,000 | 2,471,000 | 2,613,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $4,659,000 | $3,307,000 | $2,471,000 | $2,613,000 |
|
1.52% Nasdaq 
Income Statement
